AEGR stock trades between $1.6 and $1.76 before the earnings release. Let’s take a closer look at the June 2016 earnings estimates, particularly the things investors should pay close attention to. Earnings (EPS) for the recently concluded …
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company dedicated ... follows Japanese …
Stock-Callers.com has on its radar four these Biotech equities, namely: Merrimack Pharmaceuticals Inc. (NASDAQ: …
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) shares have suddenly become bullish after it was annouced that Guggenheim upgraded the stock from a “Sell” to a “Buy”, while also increasing its price target from $7.00 all the way up …
Aegerion Pharmaceuticals, Inc. is expected to report first-quarter 2016 results on May 2. The company has an impressive track record, having beaten estimates in each of the last four trailing quarters with a positive average surprise of 62%. …
Brokerage firm Guggenheim has changed its view drastically on Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR) and upgraded the company’s stock from a Sell to a Buy rating with a price target of $13.00, sending its shares up in pre …
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR): The Company declined -6.22% and finished at $1.67. The daily volume was measured at 936,837.00 shares. The 52-week high of the share price is $21.21 and the 52-week low is $1.60. The …
Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of credit risk, allowing …
Aegerion Pharmaceuticals Inc. (NASDAQ: AEGR) should have a slogan that says “We love volatility.” The biotech stock now trades for just under $60 after its earnings report, but the 52-week trading range is $29.61 to $101.00. After a poor …